Axsome Therapeutics Highlights Data on Solriamfetol Demonstr

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced five presentations, including two featured oral plenary presentations, on...

Related Keywords

Houston , Texas , United States , New York , Germany , Herdecke , Nordrhein Westfalen , American , Hans Van Dongen , Mark Jacobson , Darren Opland , Michael Thorpy , Samantha Floam , Johannes Gutenberg , Department Of Neurology , Montefiore Medical Center , Professor At Washington State University , American Academy Of Sleep Medicine , Axsome Therapeutics Inc , Corporate Communications , Drug Administration , Medicine Center , University Witten Herdecke , World Trade Center , Wake Disorders Center , Nasdaq , Research Society , Therapeutics Highlights Data , Solriamfetol Demonstrating Improvement , Cognitive Function , Obstructive Sleep Apnea , American Academy , Sleep Medicine , Sleep Research Society , Washington State University , Excessive Daytime Sleepiness , Washington State , Excessive Daytime Sleepiness Associated , Yaroslav Winter , Mainz Comprehensive Epilepsy , Sleep Medicine Center , Johannes Gutenberg University , Wakefulness Outcomes , Obstructive Sleep , Sleep Wake Disorders Center , Albert Einstein College , Real World Use , Patients Reporting Anxiety , Ulf Kallweit , Assistant Professor , Axsome Therapeutics ,